The DEA recently announced the third extension of Covid-19 flexibilities for the virtual prescribing of controlled substances. Telehealth advocates applaud this move but remain hopeful for a more permanent solution in the future.
Illinois, Kentucky, Oregon, Utah and Vermont have been authorized by HHS to provide Medicaid/Children’s Health Insurance Program coverage to those transitioning out of incarceration up to 90 days before they're released. Several healthcare leaders called the action a necessary step.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Here is a list of some of the biggest funding rounds in the payer/employer space that were announced in May.
Boulder Care's Series C funding round was led by Advance Venture Partners and included participation from Stripes, First Round Capital, Qiming Venture Partners and Laerdal Million Lives Fund. In total, Boulder Care has raised about $85 million.
HHS recently released a final rule that allows practitioners in Opioid Treatment Programs to start patients on methadone or buprenorphine via telehealth. However, the final rule does not apply to the broader range of providers, leading telehealth advocates to call for additional changes from the DEA.
As the opioid crisis grows for teens, Boulder Care has expanded its substance use disorder treatment to support adolescents. The company is starting its adolescent services in Washington with UnitedHealthcare Community Plan.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
The DEA proposed a rule back in March that would roll back some of the Covid-19 flexibilities for the virtual prescribing of controlled substances, but has since extended the flexibilities. Stephanie Strong, founder and CEO of Boulder Care, feels confident that the DEA will continue to be open to the prescribing of these medications via telemedicine.
There is inadequate substance use disorder support for people who are incarcerated or are leaving incarceration. But there are opportunities to make improvements, experts say.